Literature DB >> 27400066

Yellow Fever Remains a Potential Threat to Public Health.

Pedro F C Vasconcelos1, Thomas P Monath2.   

Abstract

Yellow fever (YF) remains a serious public health threat in endemic countries. The recent re-emergence in Africa, initiating in Angola and spreading to Democratic Republic of Congo and Uganda, with imported cases in China and Kenya is of concern. There is such a shortage of YF vaccine in the world that the World Health Organization has proposed the use of reduced doses (1/5) during emergencies. In this short communication, we discuss these and other problems including the risk of spread of YF to areas free of YF for decades or never before affected by this arbovirus disease.

Entities:  

Keywords:  Aedes aegypti mosquitoes; Epidemic; Underreporting; Vaccine; Yellow fever; Zika virus

Mesh:

Substances:

Year:  2016        PMID: 27400066     DOI: 10.1089/vbz.2016.2031

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  29 in total

1.  NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication.

Authors:  Crystall M D Swarbrick; Chandrakala Basavannacharya; Kitti W K Chan; Shu-Ann Chan; Daljit Singh; Na Wei; Wint Wint Phoo; Dahai Luo; Julien Lescar; Subhash G Vasudevan
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

Review 2.  Molecular pathogenesis of viral hemorrhagic fever.

Authors:  Christopher F Basler
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

3.  SISS-Geo: Leveraging Citizen Science to Monitor Wildlife Health Risks in Brazil.

Authors:  Marcia Chame; Helio J C Barbosa; Luiz M R Gadelha; Douglas A Augusto; Eduardo Krempser; Livia Abdalla
Journal:  J Healthc Inform Res       Date:  2019-07-03

Review 4.  Vaccines and Senior Travellers.

Authors:  Fiona Ecarnot; Stefania Maggi; Jean-Pierre Michel; Nicola Veronese; Andrea Rossanese
Journal:  Front Aging       Date:  2021-07-09

Review 5.  The use of humanized mice for studies of viral pathogenesis and immunity.

Authors:  Florian Douam; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2018-03-28       Impact factor: 7.090

6.  Single shot of 17D vaccine may not confer life-long protection against yellow fever.

Authors:  Pedro Fc Vasconcelos
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11-27       Impact factor: 2.743

7.  Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations.

Authors:  Dinair Couto-Lima; Yoann Madec; Maria Ignez Bersot; Stephanie Silva Campos; Monique de Albuquerque Motta; Flávia Barreto Dos Santos; Marie Vazeille; Pedro Fernando da Costa Vasconcelos; Ricardo Lourenço-de-Oliveira; Anna-Bella Failloux
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

8.  High risk for chikungunya virus to initiate an enzootic sylvatic cycle in the tropical Americas.

Authors:  Ricardo Lourenço-de-Oliveira; Anna-Bella Failloux
Journal:  PLoS Negl Trop Dis       Date:  2017-06-29

9.  Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204.

Authors:  Kate D Ryman; L K Metthew Lam; Alan M Watson; William B Klimstra
Journal:  NPJ Vaccines       Date:  2018-01-23       Impact factor: 7.344

10.  The Wolbachia strain wAu provides highly efficient virus transmission blocking in Aedes aegypti.

Authors:  Thomas H Ant; Christie S Herd; Vincent Geoghegan; Ary A Hoffmann; Steven P Sinkins
Journal:  PLoS Pathog       Date:  2018-01-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.